Patients & Visitors

In This Section
UH Contact Information

General Phone Number

(888) 844-8447
(216) 844-8447

Mailing Address

11100 Euclid Avenue
Cleveland, OH 44106

Helpful Links

Clinical Trials
ALL
ADHD (Attention Deficit Hyperactivity Disorder)
AIDS/HIV
Alcohol Dependance
Breast Cancer
Digestive System Cancer
Genito-Urinary Cancer
Gynecological Cancer
Head & Neck Cancer
HIV-Related Malignancies
Leukemia
Lymphoma
Melanoma
Neuro Oncology
Pediatric Oncology
Phase I
Sarcoma Oncology
Thoracic
Transplant
Alzheimer's Disease
Arthritis
Bipolar Disorders
Cervical Cancer
Colon Cancer
Crohn's Disease
Depression
Esophageal Cancer and Barrett's Esophagus
Memory Disorders
Post Traumatic Stress Disorder
Psoriasis
Skin Conditions
Diabetes
Ovarian Cancer
Sleep Apnea
Stroke
High Blood Pressure
Amyotrophic Lateral Sclerosis
Heart Failure
Spinal Cord Injury
Women's Health
Bladder Problems
Chemotherapy and Hearing
Cancer Treatment
Cervical Lesions
Glioblastoma
Hair Loss
HIV
Lupus
Myasthenia Gravis
Urea Cycle Disorders

Trial Name

NSABP B-39

A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I or II Breast Cancer ... more


E 5202

A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5-FU, Leucovorin, and Oxaliplatin versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers ... more


AIDS/HIV (A5202)

This research study is designed to learn whether different anti-HIV medication ("HAART") combinations work equally well in participants who have never taken anti-HIV medications before. ... more


NSABP B-37

NSABP B-37: A Randomized Clinical Trial of Adjuvant Chemotherapy for Radically Resected Loco-Regional Relapse of Breast Cancer. ... more


IBCSG 24-02

IBCSG 24-02: A Phase III Trial Evaluating the Role of Ovarian Function Suppression and the Role of Exemestane as Adjuvant Therapies for Premenopausal Women with Endocrine Responsive Breast Cancer ... more


S 0230

S 0230: Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Standard Adjuvant Chemotherapy in Early Stage, Hormone Receptor Negative Breast Cancer ... more


CALGB 40101

CALGB 40101: Cyclophosphamide and Doxorubicin (CA) versus Paclitaxel as Adjuvant Therapy for Women with Node-Negative Breast Cancer: A 2x2 Factorial Phase III Randomized Study ... more


NSABP B-31

A Randomized Trial Comparing the Safety and Efficacy of Adriamyci